Titers and capacity of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: a single-blinded, randomized clinical trial
bioRxiv (2022) - Comments
doi: 10.1101/2022.06.14.22276236 

Chih-Hsien Chuang, Chung-Guei Huang, Ching-Tai Huang, Yi-Ching Chen, Yu-An Kung, Chih-Jung Chen, Tzu-Chun Chuang, Ching-Chi Liu, Po-Wei Huang, Shu-Li Yang, Po-Wen Gu, Shin-Ru Shih, Cheng-Hsun Chiu